Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.05
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
13.60
Today|||52-Week Range
33.00
+11.97%
Year-to-Date

Today’s Trading

Previous close21.05
Today’s open20.75
Day’s range20.55 - 21.15
Volume962,102
Average volume (3 months)862,194
Market cap$967.7M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+540.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...0.000.00%
ZIOPZIOPHARM Oncology In...0.000.00%
ATNXAthenex Inc0.000.00%
BYSIBeyondspring Inc0.000.00%
Data as of 4:15pm ET, 12/15/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.95
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts